ABSTRACT
The aim of the present study was to evaluate the effects of yerba maté extract upon markers of insulin resistance and inflammatory markers in mice with high fat diet-induced obesity. The mice were introduced to either standard or high fat diets. After 12 weeks on a high fat diet, mice were randomly assigned to one of the two treatment conditions, water or yerba maté extract at 1.0 gkg(-1). After treatment, glucose blood level and hepatic and soleus muscle insulin response were evaluated. Serum levels of TNF-α and IL-6 were evaluated by ELISA, liver tissue was examined to determine the mRNA levels of TNF-α, IL-6 and iNOS, and the nuclear translocation of NF-κB was determined by an electrophoretic mobility shift assay. Our data show improvements in both the basal glucose blood levels and in the response to insulin administration in the treated animals. The molecular analysis of insulin signalling revealed a restoration of hepatic and muscle insulin substrate receptor (IRS)-1 and AKT phosphorylation. Our data show that the high fat diet caused an up-regulation of the TNF-α, IL-6, and iNOS genes. Although after intervention with yerba maté extract the expression levels of those genes returned to baseline through the NF-κB pathway, these results could also be secondary to the weight loss observed. In conclusion, our results indicate that yerba maté has a potential anti-inflammatory effect. Additionally, these data demonstrate that yerba maté inhibits hepatic and muscle TNF-α and restores hepatic insulin signalling in mice with high fat diet-induced obesity.
Subject(s)
Anti-Inflammatory Agents/administration & dosage , Ilex paraguariensis , Insulin Resistance , Obesity/drug therapy , Plant Extracts/administration & dosage , Adipose Tissue/drug effects , Animals , Biomarkers/metabolism , Blood Glucose/metabolism , Body Weight/drug effects , Dietary Fats/administration & dosage , Gene Expression Regulation , Inflammation Mediators/metabolism , Insulin/metabolism , Insulin Receptor Substrate Proteins/metabolism , Liver/metabolism , Male , Mice , Mice, Obese , Muscle, Skeletal/metabolism , NF-kappa B/metabolism , Nitric Oxide Synthase Type II/metabolism , Obesity/metabolism , Phosphorylation , Proto-Oncogene Proteins c-akt/metabolism , Thermogenesis/drug effects , Tumor Necrosis Factor-alpha/metabolismABSTRACT
BACKGROUND: Pro-inflammatory cytokines, such as tumour necrosis factor (TNF)-alpha, are known to be involved in the establishment of insulin resistance. Insulin resistance plays a key role in the development of obesity-related pathologies, such as type 2 diabetes and non-alcoholic fatty liver disease (NAFLD). The state of chronic inflammation associated with obesity led us to hypothesize that TNF-alpha blockade may have an effect on experimentally obese animals. AIMS: We studied the effects of thalidomide, an immunosuppressant and anti-TNF-alpha drug, on hepatic alterations that were induced by a high-fat diet (HFD) in mice. METHODS: Obesity was induced in Swiss mice using a HFD for 12 weeks. Thalidomide-treated animals received thalidomide i.p. (100 mg/kg/day, 10 days). Glucose, aspartate aminotransferases and alanine aminotransferases levels were assessed in the blood. Insulin and glucose tolerance tests were performed. The liver was excised for histological, triglyceride, gene and protein expression analyses. RESULTS: We found improvements in both the basal glucose blood levels and the response to insulin administration in the treated animals. The molecular analysis of insulin signalling revealed a restoration of the hepatic insulin receptor substrate (IRS)-1 and AKT phosphorylation. The hepatic expression of TNF-alpha was inhibited and the levels correlated with a significant reduction in the steatosis area. Other hepatic inflammatory markers, such as iNOS and suppressor of cytokine signalling (SOCS-3), were also reduced. CONCLUSIONS: We suggest that immunosuppressant drugs that target TNF-alpha and that may also contribute to reductions in the inflammatory markers that are associated with obesity could be a therapeutic option in NAFLD and type 2 diabetes.
Subject(s)
Dietary Fats/administration & dosage , Fatty Liver/drug therapy , Immunosuppressive Agents/pharmacology , Liver/drug effects , Liver/pathology , Thalidomide/pharmacology , Animals , Biopsy, Needle , Blood Glucose/analysis , Diet , Disease Models, Animal , Fatty Liver/chemically induced , Fatty Liver/pathology , Immunohistochemistry , Inflammation Mediators/analysis , Inflammation Mediators/metabolism , Insulin Resistance/physiology , Interleukin-6/analysis , Interleukin-6/metabolism , Leptin/analysis , Leptin/metabolism , Liver Function Tests , Male , Mice , Nitric Oxide Synthase/metabolism , Obesity/drug therapy , Obesity/pathology , Probability , RNA/analysis , Random Allocation , Reference Values , Reverse Transcriptase Polymerase Chain Reaction , Treatment Outcome , Tumor Necrosis Factor-alpha/analysis , Tumor Necrosis Factor-alpha/metabolismABSTRACT
The aim of the present study is to evaluate the influence of Helicobacter pylori on Bax and Bcl-2 mRNA and protein levels in patients with chronic gastritis and gastric cancer. The study included 217 patients, of which 26 were uninfected; 127 had chronic gastritis and were H. pylori-positive, and 64 had gastric cancer. Bacterial genotypes were evaluated by PCR, and the expression values were determined by quantitative real-time PCR and immunohistochemistry. Our data showed that the up-regulationary effects of H. pylori infection on the pro-apoptotic gene, Bax, were stronger than its induction of Bcl-2; this effect may increase apoptosis in patients with chronic gastritis. In patients with gastric cancer, the up-regulation of the anti-apoptotic gene, Bcl-2, counteracted the pro-apoptotic effects of Bax, leading to a deregulation of apoptosis-associated gene expression, favoring cell proliferation. Thus, the disturbance in Bax and Bcl-2 balance, induced by H. pylori, might be important in gastric cancer development.
Subject(s)
Gastritis/metabolism , Gastritis/microbiology , Helicobacter Infections/metabolism , Helicobacter pylori , Proto-Oncogene Proteins c-bcl-2/metabolism , Stomach Neoplasms/metabolism , Stomach Neoplasms/microbiology , bcl-2-Associated X Protein/metabolism , Adult , Aged , Aged, 80 and over , Apoptosis , Chronic Disease , Female , Gastric Mucosa/metabolism , Gastric Mucosa/microbiology , Gastric Mucosa/pathology , Gastritis/pathology , Helicobacter Infections/complications , Helicobacter Infections/pathology , Helicobacter pylori/genetics , Humans , Male , Middle Aged , Stomach Neoplasms/pathology , Up-Regulation , Young AdultABSTRACT
Because the potential of yerba maté (Ilex paraguariensis) has been suggested in the management of obesity, the aim of the present study was to evaluate the effects of yerba maté extract on weight loss, obesity-related biochemical parameters, and the regulation of adipose tissue gene expression in high-fat diet-induced obesity in mice. Thirty animals were randomly assigned to three groups. The mice were introduced to standard or high-fat diets. After 12 weeks on a high-fat diet, mice were randomly assigned according to the treatment (water or yerba maté extract 1.0 g/kg). After treatment intervention, plasma concentrations of total cholesterol, high-density lipoprotein cholesterol, triglyceride, low-density lipoprotein (LDL) cholesterol, and glucose were evaluated. Adipose tissue was examined to determine the mRNA levels of several genes such as tumor necrosis factor-alpha (TNF-alpha), leptin, interleukin-6 (IL-6), C-C motif chemokine ligand-2 (CCL2), CCL receptor-2 (CCR2), angiotensinogen, plasminogen activator inhibitor-1 (PAI-1), adiponectin, resistin, peroxisome proliferator-activated receptor-gamma(2) (PPAR-gamma(2)), uncoupling protein-1 (UCP1), and PPAR-gamma coactivator-1 alpha (PGC-1 alpha). The F4/80 levels were determined by immunoblotting. We found that obese mice treated with yerba maté exhibited marked attenuation of weight gain, adiposity, a decrease in epididymal fat-pad weight, and restoration of the serum levels of cholesterol, triglycerides, LDL cholesterol, and glucose. The gene and protein expression levels were directly regulated by the high-fat diet. After treatment with yerba maté extract, we observed a recovery of the expression levels. In conclusion, our data show that yerba maté extract has potent antiobesity activity in vivo. Additionally, we observed that the treatment had a modulatory effect on the expression of several genes related to obesity.
Subject(s)
Anti-Obesity Agents/therapeutic use , Body Weight/drug effects , Dietary Fats/administration & dosage , Ilex paraguariensis , Obesity/drug therapy , Phytotherapy , Plant Extracts/therapeutic use , Adipokines/genetics , Adipokines/metabolism , Adipose Tissue/drug effects , Animals , Anti-Obesity Agents/pharmacology , Blood Glucose/metabolism , Cell Migration Assays, Macrophage , Cholesterol/blood , Diet , Disease Models, Animal , Gene Expression Regulation , Mice , Mice, Obese , Plant Extracts/pharmacology , RNA, Messenger/metabolism , Random Allocation , Weight Gain/drug effectsABSTRACT
The antioxidant activity of mate tea, the roasted product derived from yerba mate (Ilex paraguarienis), was observed in vitro and in animal models, but studies in humans are lacking. The aim of this study was to investigate the effects of mate tea supplementation on plasma susceptibility to oxidation and on antioxidant enzyme gene expression in healthy nonsmoking women, after acute or prolonged ingestion. We evaluated plasma total antioxidant status (TAS), the kinetics of diene conjugate generation, and thiobarbituric acid reactive substance (TBARS) contents in plasma, as well as mRNA levels of antioxidant gluthatione peroxidase (GPx), superoxide dismutase (SOD), and catalase (CAT). After the supplementation period with mate tea, lipid peroxidation was acutely lowered, an effect that was maintained after prolonged administration. Total antioxidant status and the level of antioxidant enzyme gene expression were also demonstrated after prolonged consumption. These results suggest that regular consumption of mate tea may increase antioxidant defense of the body by multiple mechanisms.
Subject(s)
Antioxidants/metabolism , Gene Expression Regulation, Enzymologic/drug effects , Glutathione Peroxidase/genetics , Ilex paraguariensis/chemistry , Lipid Peroxidation/drug effects , Plant Extracts/administration & dosage , Superoxide Dismutase/genetics , Adult , Eating , Female , Glutathione Peroxidase/metabolism , Humans , Superoxide Dismutase/metabolism , Thiobarbituric Acid Reactive Substances/metabolism , Women's Health , Young AdultABSTRACT
OBJECTIVE: Helicobacter pylori infection is related to gastric cancer development, and chronic inflammation is presumed to be the main cause. The aim of the present study was to evaluate the influence of H. pylori cagA, vacA, iceA, and babA genotypes on COX-2, IL-1beta, and IL-8 expression. MATERIAL AND METHODS: Of the 217 patients included in the study, 26 were uninfected, 127 had chronic gastritis and were H. pylori-positive, and 64 had gastric cancer. Bacterial genotypes were evaluated by polymerase chain reaction (PCR), and the expression values were determined by quantitative real-time PCR and immunohistochemistry. RESULTS: An association was found between the infection with cagA, vacA s1m1 strains and gastric cancer development. Regarding the 3' region of the cagA gene, we also found an association between the infection with cagA EPIYA-ABCCC strains and clinical outcome. Higher levels of IL-8, IL-1beta, and COX-2 were detected in gastric mucosa from infected patients with chronic gastritis, and they were also associated with the infection by cagA, vacA s1m1 strains. The IL-8 and IL-1beta levels decrease significantly from chronic gastritis to gastric cancer, while the relative expression remained unaltered when COX-2 expression was analyzed among patients with gastritis and cancer. CONCLUSIONS: Since inflammatory response to H. pylori infection plays an important role in cellular proliferation and gastric mucosal damage, the up-regulation of IL-1beta, IL-8, and COX-2 in patients with chronic gastritis has an important clinical implication in gastric carcinogenesis.
Subject(s)
Cyclooxygenase 2/genetics , Gastritis/microbiology , Helicobacter Infections/genetics , Helicobacter pylori/genetics , Interleukin-1beta/genetics , Interleukin-8/genetics , Stomach Neoplasms/microbiology , Adult , Aged , Aged, 80 and over , Cyclooxygenase 2/biosynthesis , Female , Gastritis/genetics , Gastritis/metabolism , Gene Expression , Genotype , Humans , Interleukin-1beta/biosynthesis , Interleukin-8/biosynthesis , Male , Middle Aged , Stomach Neoplasms/genetics , Stomach Neoplasms/metabolism , Up-RegulationABSTRACT
The aim of this study was to evaluate the relationship among oxidative DNA damage, density of Helicobacter pylori and the relevance of cagA, vacA and iceA genotypes of H. pylori. Gastric epithelial cells were isolated from 24 uninfected patients, 42 H. pylori infected patients with gastritis, and 61 patients with gastric cancer. Oxidative DNA damage was analyzed by the Comet assay, the density of H. pylori was measured by real-time polymerase chain reaction (PCR), and allelic variants of cagA, vacA and iceA were identified using the PCR. Infected patients by Helicobacter pylori cagA(+), vacAs1 m1 and iceA1 genotype showed higher levels of oxidative DNA damage than infected patients with H. pylori cagA(-), vacAs2 m2 and iceA2 genotypes and uninfected patients. Density of H. pylori did not influence oxidative DNA damage. Our results indicate that H. pylori genotype is more relevant than density for oxidative DNA damage.
Subject(s)
Antigens, Bacterial/genetics , Bacterial Outer Membrane Proteins/genetics , Bacterial Proteins/genetics , DNA Damage/genetics , DNA, Bacterial/genetics , Gastric Mucosa/pathology , Helicobacter pylori/genetics , Adult , Aged , Aged, 80 and over , Antibodies, Bacterial/immunology , Biopsy , Cell Count , Comet Assay , Female , Gastric Mucosa/microbiology , Genotype , Helicobacter Infections/microbiology , Helicobacter Infections/pathology , Helicobacter pylori/immunology , Helicobacter pylori/metabolism , Humans , Male , Middle Aged , Polymerase Chain Reaction , Prospective StudiesABSTRACT
OBJECTIVE: Antiacid drugs, including omeprazole and ranitidine, were prescribed to Helicobacter pylori-infected subjects in combination with antibiotics during eradication treatment. Several reports suggest that these drugs have additional pharmacological properties, such as antineutrophil, antiapoptotic and antioxidant characteristics. The aim of this work was to study the effects of acid suppressive medication treatment in the H. pylori infection experimental model, focusing on possible additional pharmacological properties. MATERIAL AND METHODS: The ability of gastric acid suppression was assessed in pylorus-ligated animals. Gastric H. pylori colonization levels, myeloperoxidase (MPO) acitivity, macroscopic damage, Bax and Bcl-2 expression and DNA damage levels were assessed in C57BL/6-infected mice after treatment for one week with omeprazole (100 mg kg(-1)) or ranitidine (100 mg kg(-1)). RESULTS: Omeprazole treatment increased bacteria colonization and MPO activity in mice stomachs. Both antiacid drugs efficiently improved macroscopic damage, although only omeprazole restored the expression of the antiapoptotic Bcl-2 protein in gastric mucosa of infected animals. CONCLUSIONS: Some additional omeprazole-related properties, such as antineutrophil properties, were not observed in H. pylori-infected mice after one week of treatment, suggesting that this property is restricted to in vitro approaches. However, the antiapoptotic activity of omeprazole could be attributed to an ability to modify the protein expression of Bcl-2, decreased by H. pylori infection.